Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 220-225, February 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomson, M. J.
Right arrow Articles by Richards, J. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomson, M. J.
Right arrow Articles by Richards, J. F.

Hormonal Effects on Thymidine Kinase and Thymidylate Kinase Activity of Estrogen-dependent Tumors in the Rat1

Marnie J. Thomson, Maureen R. Garland and James F. Richards

Cancer Research Centre [M. J. T., M. R. G., J. F. R.], and Department of Biochemistry, [J. F. R.], University of British Columbia, Vancouver, British Columbia, Canada

In estrogen-induced, estrogen-dependent, mammary and adrenocortical carcinomas, the specific activities of the thymidine kinase and thymidylate kinase decreased significantly within 2 to 4 days after removal of the source of estrogen of the host. After 7 days, these changes were even more marked in the adrenal tumors. Similar changes were not observed in the activity of these enzymes in autonomous tumors in response to alterations in the supply of estrogen to the host. The treatment with antiestrogenic compounds of estrogenized animals bearing dependent adrenal tumors also caused a decrease in the activity of the two enzymes. The replacement of estrogen by treatment with adrenocorticotropic hormone in animals with adrenal tumors caused a stimulation of kinase activity at 2 days but did not prevent the decrease observed at 7 days after the removal of estrone. Growth of the mammary and adrenocortical carcinomas, as indicated by activity of the kinases, was maintained after estrogen removal by treatment of the host with prolactin.

1 This work was supported in part by the Medical Research Council of Canada.

Received 8/10/72. Accepted 10/18/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.